DEVELOPMENT OF THE METHODOLOGY OF THE CHROMATOGRAPHIC DETERMINATION OF NIFEDIPINE IN MEDICINES
Objective: The aim was to develop a simple, rapid, less expensive, linear, precise, and accurate reverse phase high performance liquid chromatography
method for determination of nifedipine in tablets.
Methods: The chromatographic analysis of nifedipine was performed using liquid chromatograph Agilent 1290 Infinity II LC System. Selected
conditions were isocratic elution with binary mobile phase consisting of solution methanol and 0.1% trifluoroacetic acid (55:45). Detection was
carried out using spectrophotometric detector at 265 nm. The method was validated as per ICH guidelines.
Results: The retention time for nifedipine by proposed high performance liquid chromatography (HPLC) method is observed as 3.5 minutes. The
correlation coefficients are 1.0000. The developed chromatographic method was found to be accurate with recovery 99.2-99.8% and was found
within the acceptance criteria (i.e. 98.0-102.0%) with acceptable % relative standard deviation of not more than 2% at each level. The assay results of
nifedipine in tablets by developed method are highly reproducible, reliable and are in good agreement with the label claim of the medicines (average
Conclusion: Finally, it should be noted that a new simple, rapid, linear, precise, accurate HPLC method was developed and validated for the
determination of nifedipine in medicines in accordance with the ICH guidelines. These results show the method are accurate, precise, sensitive,
economic, and rugged. The proposed HPLC method is rapider (retention time is 3.5 minutes). This method can be useful for the routine analysis of
nifedipine in pharmaceutical dosage form.
Keywords: Nifedipine, High-performance liquid chromatography, Validation, Linearity, Accuracy, Range of application.
1. Siddiqui MR, AlOtthman ZA, Rahman N. Analytical techniques in pharmaceutical analysis: A review. Arabian J Chem 2013;138:1395-404.
2. Katz E. Quantitative Analysis Using Chromatographic Techniques. New York: John Wiley & Sons; 2009. p. 1-427.
3. Nageswara Rao R, Nagaraju V. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs. J Pharm Biomed Anal 2003;33(3):335-77.
4. Bakar RA, Miran H. Validated high performance liquid chromatography (HPLC) method for analysis of methamphetamine in human urine using liquid-liquid extraction. Asian J Pharm Clin Res 2015;8(2):199-201.
5. Patil R, Deshmukh T, Patil V, Khandelwal K. Review on analytical method development and validation. Res Rev J Pharm Anal 2014;3(3):1-10.
6. Handler J. Quality of life and antihypertensive drug therapy. J Clin Hypertens (Greenwich) 2005;7(5):274-85.
7. United States Pharmacopoeia (USP). Medicare Prescription Drug Benefit Model Guidelines Source Information. Available from: http://www.nlm.nih.gov.
8. State Pharmacopoeia of Ukraine. State Enterprise Ukrainian Scientific Center Pharmacopoeia Quality Medicines. 2nd ed. Vol. 3. Kharkiv: State Enterprise Ukrainian Scientific Center of Quality Pharmacopoeia of Medicines; 2014. p. 724.
9. State Pharmacopoeia of Ukraine/State Enterprise. Scientific and Expert Centre Pharmacopoeia, Appendix 2. 1st ed. Kharkiv: State Enterprise Ukrainian Scientific Center of Quality Pharmacopoeia of Medicines; 2008. p. 620.
10. Logoyda L. Validation of chromatographic methods of analysis for the determination of active pharmaceutical ingredients in different medicines. Mansoura University (Egypt): Pharma School Association for Pharmaceutical Development and Scientific Research; 2016. p. 34.
11. ICH. Q2A Text on Validation of Analytical Procedures. Geneva: International Conference on Harmonization; 1994.
12. ICH. Q3B Validation of Analytical Procedures: Methodology. Geneva: International Conference on Harmonization; 1996.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.